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Short summary (WC=28 of 30): 
The burden of STI in Comarca Ngäbe-Buglé high-school adolescents, is similar or higher than in 
urban Panama. There is urgent need to implement targeted screening and other interventions. 
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Abstract  
Background: There is scant information on STI prevalence and risk factors among Latin 
American indigenous populations. We investigated STI prevalence and risk factors among 
adolescents of the Comarca Ngäbe-Buglé (CNB) indigenous region of Panama.  
 
Methods: A population-based cross-sectional study was conducted among school-going 
adolescents aged 14-19-years. Eligible consenting participants self-completed a questionnaire 
and provided blood and urine samples. Females provided additional self-administered genital 
swabs. Seroprevalences of HIV, syphilis, hepatitis B (HBsAg, anti-HBc) and herpes simplex 
virus type-2 (HSV-2) were determined in all participants; genital Chlamydia trachomatis (CT) 
and Neisseria gonorrhoeae (NG) by PCR among participants who reported sexual experience or 
were seropositive for HIV/syphilis/HSV2/HBsAg; high-risk HPV by qualitative DNA assay and 
bacterial vaginosis (BV) by Gram-stain among females. Risk factors were identified by 
estimating adjusted odds-ratios (AOR) using random-effects logistic regression. 
 
Results: We enrolled 700 participants (median age: 17 years [females], 18 years [males]) from 
20 schools. Sexual experience was reported by 536 participants (76.6%). HIV/STI prevalences 
among females and males were: HIV 0.4% and 1.0%, high-titer active syphilis 1.3% and 6.6%, 
HSV-2 16.1% and 16.1%, HBsAg 1.3% and 1.4%, anti-HBc 3.2% and 1.4%, NG 1.8% and 
1.7%, CT 17.5% and 10.7%; among females: BV 42.9% and HPV 33.2%. CT was independently 
associated with being female (AOR=2.02, 95%CI:1.20-3.41); high-titer active syphilis with 
being male (AOR=4.51, 95%CI:1.17-17.40). BV was associated with sexual behavior (3 
lifetime sex partners, AOR=3.81, 95%CI:1.29-11.26), HPV with sexual experience (AOR=4.05, 
95%CI:1.62-10.09).  
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Conclusions: School-going indigenous adolescents in rural Panama have substantial STI burden. 
Targeted STI screening is required. 
 
Key words: STI, adolescents, indigenous populations, schools, Panama 
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Introduction 
Sexually transmitted infections (STIs) are commonly acquired during adolescence and, if left 
untreated, can lead to poor sexual and reproductive outcomes, such as pelvic inflammatory 
disease, infertility and enhanced HIV vulnerability (1). Indigenous peoples, particularly those 
who live in rural areas, are especially vulnerable to STIs due to unequal access to healthcare, 
especially to STI treatment and care (2). 
 
In Panama, indigenous peoples make up 12.2% of the total population. The Comarca Ngäbe-
Bugle (CNB) is Panama‟s most populated indigenous region with over 200,000 individuals, with 
the country´s highest levels (93.4%) of multidimensional poverty (3). Prevalence of HIV among 
15-24-year-old females and males in Panama is estimated at 0.3% and 0.5%, respectively (4). 
However, in CNB, Ministry of Health (MOH) data show that, between 2013-2017, 2.1% 
(868/41,982) of rapid HIV tests performed were positive, with 82.0% of HIV infections in males, 
and 16.7% in 14-19-year-old male and females (5). As in other low- and middle-income 
countries, most STIs are managed syndromically in Panama, with little STI screening or 
etiological surveillance, except for prenatal MOH data which estimated maternal syphilis as 
1.94% in 2017 (6). Furthermore, CNB-MOH data indicate low prevalence of hepatitis B virus 
(HBV), whilst no data exists for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), or 
high-risk human papillomavirus (HR-HPV) (6). Vaccination against HPV genotypes 16 and 18 
was rolled out in 2008 through a school-based program targeting 10-year-old females (7). In 
2015, the tetravalent vaccine was substituted in the same age group; in 2016, 10-year-old males 
were included (8). Despite universal rollout of HPV vaccination, monitoring of uptake is not 
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available. While some national STI data are stratified by region, they are not by ethnicity. 
Specifically, there are no MOH data on STIs among indigenous youth of CNB. 
 
The World Health Organization (WHO) Strategy on STIs 2016-21 defines the global strategy for 
the prevention and control of STIs (9). The first strategic direction is to collect laboratory 
diagnosed epidemiological data on STIs, to plan, fund, and undertake effective targeted 
interventions. To inform this strategic direction, we conducted the first community-based 
prevalence study of STIs focused on school-going indigenous adolescents in CNB. 
 
Methods 
Between July-November 2018, we conducted a cross-sectional study among male and female 
adolescent students aged 14-19 years, enrolled in high-schools (7
th
-12
th
 grades), using two-stage 
cluster sample design with random sampling of clusters, and equal probability of selection 
(Figure 1).  
 
Study procedures  
The sampling frame was the 20 largest CNB high-schools, equating to 41.7% of all CNB high-
school students. Schools were arranged in 5 groups of 4, in decreasing order by enrolment 
numbers. Two schools were randomly selected from each group. Then, all 7
th
-12
th
 grade 
classrooms in selected schools were ordered by decreasing classroom size, arranged into groups 
of ten, from which two classrooms were selected until about 1100 14-19-year-old individuals 
were selected; we assumed two-thirds would agree to participate (10). The primary outcome of 
interest in the study was STI prevalence among adolescents 14-19y who had engaged in sexual 
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intercourse at least once. A final sample size of 700 14-19y students was estimated, based on an 
assumed design effect of 2, 5% precision for STI prevalence estimates, 20% prevalence of the 
most common STI (CT), assuming two-thirds of participants had engaged in sex, based on 
previous school-based sexual health studies in Panama (10).  
 
Guardians of minor students (aged <18y) from selected classrooms were invited by letter to 
attend an informational meeting and were requested to bring their child‟s vaccine card. During 
the meeting, study objectives and procedures were explained. Guardians were then asked to 
provide signed informed consent. If available, details of HBV and HPV vaccinations were 
logged. After the meeting, eligible students were provided with information individually, asked 
to provide signed informed assent (if <18y) or consent (≥18y). Participants were assigned a 
unique identification code and given an appointment card with the date (within 3-4 weeks) to 
retrieve their laboratory results and treatment at a designated MOH clinic. At the schools, 
participants completed a self-administered questionnaire and provided blood and urine samples. 
All female participants went to the health center to provide additional self-collected genital 
swabs.  
 
Data were obtained for socio-demographics and sexual behavior including vaginal/anal/oral sex, 
forced sex, and same-sex sexual activity, (further defined in Supplementary Table 1) with a 
self-completed questionnaire using a tablet computer (Kobo Toolbox, Harvard Humanitarian 
Initiative, MA, USA). All participants, regardless of reported sexual behavior, were asked to give 
blood and urine samples, and self-collected swab samples (females only). Participants were 
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expected to complete the questionnaire and biological sampling on the same day as 
consent/assent; however, if necessary, some activities were completed the following day.   
 
Blood samples (8ml) were tested with rapid HIV and syphilis tests in the field laboratory; 
confirmatory tests for these infections and HBV and HSV-2 serologies were performed at the 
Provincial MOH blood bank laboratory in nearby Santiago. Participants were asked to provide a 
40ml first-void urine sample in a sterile cup for CT/NG testing. To limit costs, we only included 
CT/NG testing in participants who reported sexual experience, or tested positive for any 
HIV/STI serology (syphilis, HBV or HSV-2). All female participants were instructed to provide 
two self-collected vaginal swabs (11), a high-vaginal Dacron swab (5cm insertion) for HPV 
testing, and a dry-cotton lower-vaginal swab (3cm insertion) for BV testing. Dacron swabs were 
placed immediately in a CerviCollect transportation tube (Abbott Molecular, IL, USA), and 
transported to the Gorgas Memorial Laboratory in Panama City at weekly intervals. Lower-
vaginal swabs (Copan Diagnostics Inc., CA, USA) were rolled onto a glass slide by a health 
technician, air-dried, fixed with methanol, transported weekly to the MOH Microbiology 
Laboratory in Santiago. Participants were offered a minimum 3-hour group education session, 
which included the topics: self-esteem, sexual decision making, dating violence, transmission 
and prevention of HIV/STIs.  
 
Within one day of submitting their sample, participants testing HIV-positive by rapid test were 
counselled and referred to the closest HIV clinic for assessment and antiretroviral therapy (ART) 
initiation. All treponemal antibody-positive cases were offered treatment upon receiving 
confirmation within 5 days of submitting their sample. All participants were reminded by school 
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counselors to collect other test results during their scheduled appointment. All participants with a 
positive test for a curable STI were provided standardized STI treatment and patient-initiated 
notification, according to Panama guidelines (12). Participants with positive CT or NG who did 
not retrieve their results were traced and treated as per MOH guidelines (12). 
 
Laboratory methods 
Blood samples were collected at each school. A temporary study laboratory was housed within 
the closest MOH clinic for HIV and syphilis testing. HIV testing was undertaken according to 
national guidelines (13) using two rapid tests from different manufacturers: Alere Determine 
HIV-1/2 Ab (Inverness Medical Japan Co, Chiba, Japan), confirmatory testing using SD Bioline 
HIV-1/2 3.0 (Standard Diagnostics, Inc., Gyeonggi-do, South Korea). For syphilis testing, a 
point-of-care treponemal assay (Alere Determine
TM
 TP, Inverness Medical Japan Co, Chiba, 
Japan) was used, with confirmation using a non-treponemal assay (VDRL, Weiner Lab, Rosario, 
Argentina) with assay titration. Treponemal seroreactivity was defined as positivity to the 
treponemal assay, whilst active syphilis was defined as the dual positivity to treponemal and 
non-treponemal assays independent of titration, although titers were recorded with reactivity at 
1:8 concentration considered „high-titer‟. Participants with positive treponemal and non-
treponemal (any titer) assays were treated. External control for HIV was performed with the 
College of American Pathologists (CAP) schemes, where concordance with other CAP users was 
98.8%. External control of syphilis testing was undertaken using 24 panels from the Curie 
Laboratory in Panama, with 100% concordance.  
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At the Santiago MOH Bloodbank Laboratory, serological samples were tested to detect HSV-2 
antibodies (Focus Diagnostic, Cypress, CA), HBV surface antigen [HBsAg] and total HBV core 
antibodies [anti-HBc] (Bio-Rad Laboratories, Hercules, CA, USA). The laboratory participated 
in quarterly MOH Quality Assurance testing for bloodborne infections (HBsAg, anti-HBc), 
where performance has been certified as “Excellent” in 9 assessments prior to the study; HSV-2 
testing concordance with other CAP laboratory users was 100%. 
 
At the Santiago MOH Microbiology Laboratory, vaginal swabs were Gram-stained and analyzed 
using the Nugent‟s score: 0-3 was classified as healthy; 4-6 as intermediate microbiota; and 7-10 
as BV (13). Study microbiologists (MH and GH) were trained at University of Alabama, USA, 
read the slides independently and undertook double reading in ~20% of slides. 
 
At the Gorgas Genomics laboratory in Panama City, urine samples were tested for CT and NG 
using RealTime CT/NG polymerase chain reaction (Abbott Molecular, IL, USA). High-vaginal 
swabs were tested with a qualitative high-risk HPV genotypes detection assay (Abbott RealTime 
High-Risk HPV, Abbott Molecular, IL, USA) that distinguishes HPV16 and/or HPV18 from 12 
other high-risk/probable HR-types (31,33,35,39,45,51,52,56,58,59,66,68). The laboratory 
enrolled in the CAP CT/NG and HPV testing schemes; concordance with other CAP users was 
98.2% for HPV, 100% for both CT and NG. 
 
Statistical methods 
Questionnaires were uploaded into the Kobo Toolbox cloud, imported and analyzed in STATA 
V15.0 (StataCorp, TX, USA). Participants who completed the questionnaire and gave at least 
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one biological sample were included in the analyses. We used the 2 test to evaluate the 
difference in STI prevalence between males and females, age, and key sexual behavior variables, 
and Fisher‟s Exact Test where appropriate. Kruskal-Wallis Test was used to evaluate associative 
trends in age, biological sex, and sexual behavior variables. Missing data were excluded.  
 
Random-effects logistic regression was used to calculate odds-ratios (OR) and 95% confidence 
interval (CI) for each pathogen adjusting for school-level clustering (14). Variables associated 
with each pathogen at p<0.2 in univariable analyses were included in initial multivariable models 
adjusting for sex and age (a-priori). In the model, distal variables were included first, then 
proximal variables (15). The final model included variables independently associated with 
outcomes at p<0.1. 
 
Ethics 
The research was approved by the Comité Nacional de Bioética de la Investigación de Panamá 
(EC-CNBI-2016-05-25, November 2017), and the London School of Hygiene & Tropical 
Medicine, UK (Ref:14558; January 2018).  
 
Results 
Study population 
Overall, 2006 students were assessed for eligibility, of whom 1101 (55%) were eligible (aged 14-
19y). A total of 380/380 (100%) eligible minor participants had guardian consent, signed their 
assent, and were present during the week the study team visited the community; one minor 
subsequently withdrew assent. Separately, a total of 321/354 (90.7%) eligible 18-19y adolescents 
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consented to participate and were available during the visit week (Figure 1). Overall, we 
included 316 (45.1%) female and 384 (54.9%) male participants (Table 1), median age was 17y 
(interquartile range [IQR], 14-19) for females, 18y (IQR, 16-18) for males. The majority of 
participants (91.3%) were of Ngäbe ethnicity (Table 1). 
 
Few participants had vaccination records and brought them to the study (22.8%, [72/316] 
females, 19.0% [73/384] males). Of these, 61.1% (44/72) females and 69.9% (51/73) males had 
1 HBV vaccine dose; and 33.3% and 32.9% had full 3-dose vaccination. For HPV vaccination, 
38.9%, 15.3% and 11.1% of females had full (three), two, one dose, respectively. Male 
participants were too old to have been included in the country-wide HPV vaccination, therefore 
none had HPV vaccination records. 
 
Sexual behavior 
Most participants reported previous sexual experience: 74.1% [234/316] of females, 78.7% 
[302/384] of males. Those who reported sexual experience were older (92.4% of 19 year-olds 
versus 52.9% of 14 year-olds) and studying in the coastal region (Ño Kribo) compared to those 
from the mountainous southern regions (86.6% versus 63.2%, p<0.01) (Table 1). The median 
age of sexual debut was 15y (IQR, 14-16) among females, and 16y (IQR, 14-17) among males 
(Table 2). A high proportion of both sexes reported forced sex, although females were more 
likely to report this than males (36.2% versus 18.2%, p<0.01) (Table 2). History of pregnancy 
was reported by 11.3% of females, whilst 6.0% of males reported having impregnated a partner. 
Ten male participants reported no sexual experience, although they were HSV-2 seropositive, 
and thus assumed to be sexually-experienced in further analyses (Table 3). 
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HIV and STI prevalence  
All HIV cases (females 0.4%, males 1.0%) were new diagnoses. Among all participants, 
treponemal seroreactivity was more prevalent among males than females (7.7% versus 3.5%; 
p=0.05), as was high-titer (1:8) active syphilis (6.6% versus 1.3%; p=0.003), with the following 
titer distribution: 9.1% (2/22) had 1:2, 9.1% (2/22) had 1:8, 13.6% (3/22) had 1:16, 22.7% (5/22) 
each had 1:32, 1:64 and 1:128 titers. There were no differences in seroprevalence of HBV 
markers by sex (HBsAg females: 1.3%; males: 1.4%; p=0.93), anti-HBc females: 3.2%; males: 
1.4%; p=0.18); and in HSV-2 seroprevalence (females: 16.1%; males 16.1%; p=0.99).  
 
Among participants who were sexually-experienced, prevalence of CT was higher in females 
(17.4% versus 10.7%; p=0.03) (Table 3), whilst NG prevalence was similar in both sexes 
(females 1.8% versus males 1.7%; p=0.95).  
 
Among females, no HPV genotypes 16 or 18 were detected, however 27.9% (95%CI:22.7-33.9) 
of all females, and 33.2% (95%CI:26.8-40.2) of those who reported sexual experience tested 
positive for other HR-HPV genotypes. 
Overall, 100% of NG and 64% of CT-positive cases were treated within four weeks, and 93% 
CT-positive within 8 weeks. Within four weeks, 51% of HR-HPV returned for their results, 46% 
of BV-positive cases returned and were treated.  
 
Factors associated with STIs 
There were no statistical significant associations between participant´s age, age of sexual debut, 
partner´s age at sexual debut, or reported condom use at last coitus with any STI 
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(Supplementary Figure 1). After adjusting for age, CT was associated with female sex 
(adjusted odds-ratio [AOR]=2.02, 95%CI:1.20-3.41) (Supplementary Table 1). Active syphilis 
was strongly associated with being male (AOR=4.51, 95%CI:1.17-17.40), weakly associated 
with reported forced sex (AOR=2.43, 95%CI:0.89-6.62), and reported transactional sex 
(AOR=2.49, 95%CI:0.82-7.57, Supplementary Table 2). Among male participants, active 
syphilis was independently associated with reported forced sex (7/52 [13.5%] versus no-forced 
sex 11/231 [4.8%], AOR=3.11, 95%CI:1.14-8.45) and weak evidence of association among 
those who reported transactional sex (5/40 [12.5%] versus no-transactional sex 13/247 [5.3%], 
AOR= 2.57, 95%CI:0.86-7.65), and those who reported same-sex sex (4/26 [15.4%] versus no 
report 11/204 [5.4%], AOR=1.52, 95%CI:0.84-2.75). 
 
Region of CNB was strongly associated with HSV-2 seropositivity in both sexes, and BV 
prevalence among female participants, with highest prevalence of both infections among 
participants from the coastal region of Ño Kribo compared to the southern mountainous regions 
(Supplementary Tables 3 and 4).  
 
Among females, there was a strong association between BV and reported sexual experience 
(AOR=2.86, 95%CI:1.39-5.91), number of lifetime sexual partners (>3 compared to one, 
AOR=3.81, 95%CI:1.29-11.26), and same-sex sex (compared to non-report, AOR=4.68, 
95%CI:0.87-25.11) (Supplementary Table 5). HR-HPV infection was associated with reported 
sexual experience (AOR=4.05, 95%CI:1.62-10.09) (Supplementary Table 6). In the adjusted 
analysis, participants who tested positive for HR-HPV had 1.81 times the odds of testing positive 
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for BV than those without HR-HPV (95%CI:1.02-3.22). Participants with NG had 14.73 times 
the odds of testing positive with CT (95%CI:3.47-62.4). 
 
Discussion 
We conducted the first study of HIV/STI prevalence and sexual behavior among indigenous 
adolescents living in a Comarcal area of Panama, and found a very high prevalence of 
chlamydia, syphilis, BV and HR-HPV in this population, indicating high vulnerability and great 
need for interventions. Understanding regional and national STI epidemics through the collection 
of STI prevalence data is essential to develop interventions targeted for high-risk groups to 
achieve STI control (9). 
 
Syphilis prevalence was remarkably high (5.6% in both sexes combined) compared to that found 
in a similar study conducted in 2015 among sexually-experienced school-going adolescents (14-
19y) living in urban areas of Panama (0.0% overall) (10). High-titer treponemal infection was 
particularly high among male adolescents. Results were comparable to, or higher than, adult 
indigenous peoples of Honduras and the Peruvian Amazon (16). In the absence of reported yaws 
cases in Panama since 1977 (17) and given the high proportion of high-titer active syphilis found 
exclusively among sexually-experienced adolescents, it can be inferred that this is recent 
exposure to sexually-transmitted treponemal infection. Among males, same-sex sex was weakly 
associated with active syphilis, which accords with the general epidemiology of syphilis among 
men who have sex with men (MSM) in Latin America (18). We found high prevalence of forced 
sex among both sexes, and among male participants this activity was strongly associated with 
active syphilis infection, similar to that found among young men in Ecuador (19). The 0.8% HIV 
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prevalence is a worrying finding in this young population and was higher than among most adult 
indigenous populations in Latin America (16).  
 
Chlamydia prevalence was also high in both sexes, although lower for females than in the study 
of adolescents in Panama City (30.9% in females, 6.2% in males) (10). Sex differences are 
comparable to those observed worldwide (1). Despite the impact of CT on sexual and 
reproductive health, there are limited control options for chlamydia infection which impact 
sequelae (1, 20). Specifically, there are no CT screening programs in Panama, as CT/NG 
infections are managed syndromically (12).  
 
The prevalence of BV was also high in our study population, greater than among adolescents in 
Ecuador (21), but comparable to BV prevalence among adolescent females in South Africa and 
Tanzania (22, 23). It is likely that some BV-associated bacteria are sexually-transmitted (24), yet 
school-based studies have reported prevalent BV among females who reported never having 
penile-vaginal sex (23). This may be due to under-reporting of sexual activity (25). In our study, 
BV was strongly associated with reported sexual activity, but was also found among those who 
did not report any type of sexual activity. Similarly, we found several cases of HSV-2 
seropositivity among males who did not report sexual activity, although oral-genital transmission 
may explain some cases. Study staff emphasized confidentiality of results to both parents and 
participants, although students may still have feared disclosure. Interestingly, we found BV to be 
associated with HR-HPV infection. A causal link has been hypothesized in a recent meta-
analysis, where BV has been found to be associated with HR-HPV persistence and the 
development of high-grade cervical neoplasia (26). 
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The absence of HPV16/18 genotypes among female adolescents is encouraging and had not been 
previously documented in Panama. It suggests possible success of the universal school-based 
HPV vaccination program that was rolled-out in 2008. However, it is difficult to ascribe a direct 
effect of the vaccination program, as too few participants produced vaccination records, and a 
large proportion of female participants had not received the recommended full-dose vaccination 
regimen, although it is plausible that a suboptimal number of doses may still provide sufficient 
protection (27). The high prevalence of other HR-HPV genotypes indicates this population is still 
highly vulnerable, as reported elsewhere (28). Additionally, if elimination of cervical and other 
HPV-related cancers were to be achieved, Panama will need to include a broader range of high-
risk genotypes in the country-wide vaccination (29). Prevalence of HBV was low compared to 
other studies among adult indigenous populations in Latin America (16). Hepatitis B vaccination 
has been rolled out among infants in Panama since 2002, although in the few vaccination records 
produced, compliance with vaccination schedule appeared low. Catch-up vaccination for both 
HPV and HBV may be advantageous for those who have incomplete vaccination records.  
  
Strengths of our study included testing a large panel of STIs among a highly vulnerable under-
researched indigenous population, using population-based sampling and laboratories with 
excellent EQA results. We used electronic data-capture and self-completed questionnaires to 
mitigate reporting bias inherent in collecting sensitive behavior data. This study had some 
limitations. Firstly, we may have encountered selection bias due to the school-based sampling; 
only about half of guardians consented their minor child‟s enrolment. More at-risk adolescents 
may have thus been excluded, leading to an underestimated STI prevalence. Moreover, male 
participants were over-represented in our sample, as more males attend school. Finally, for 
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logistical reasons, only the 20 largest schools were included in the sampling, which would have 
excluded adolescents who do not attend school or attend smaller schools. Second, CT/NG testing 
was not extended to the entire population, but only to those reporting sexual debut or found to be 
seropositive for an STI. Among females, genital self-swabbing was optional and nearly a quarter 
(23.1%) declined. To overcome these possible reporting and selection biases, we tested samples 
of participants who were positive for any of the serological markers, regardless of reported 
sexual debut. Few participants with HPV (n=6) or BV (n=10) were additionally identified. HPV 
transmission may still be possible in sexually-inexperienced females through fomites and non-
penile-vaginal sex (30). Third, reporting biases may have arisen from the self-reported nature of 
the questionnaire. We carefully piloted the use of the tablet-computers with consistent results, 
and other studies have demonstrated high rates of disclosure of sensitive behavior using such 
methods (31s). 
 
In line with the first target of the worldwide WHO Strategy for STI Control, this study has 
collected data which estimate the epidemiological STI burden among a vulnerable indigenous 
population in rural Panama. Our results underscore the need for swift coordinated action, 
focusing on the development of control programs for the WHO-prioritized infections, ie HIV, 
syphilis, HBV and HPV. Specifically, programs should be developed for CT screening among at-
risk youth. In developing these interventions, it will be imperative to take Ngäbe and Buglé 
culture into account, as culturally congruent messages are more effective in delivering sexuality 
education curricula (32s).  
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Figure 1 Study flow chart, Comarca Ngäbe-Bugle, Panama, 2018 
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Table 1: Characteristics of participants, by reported history of sexual activity, Comarca Ngäbe-Bugle, Panama, 2018 
 
   
All Participants
1
  
 Reported sexual activity  
 
 
No Yes p-value
2
 
 
n/N % n/N % n/N % 
 Participant sex 
 
 
 
 
 
 0.15 
Female 316/700  45.1 82/316 27.9 234/316 74.1 
 Male 384/700  54.9 82/384 21.4 302/384 78.7 
 Age 
 
 
 
 
 
 <0.01 
14-15 years 157/700  22.4 74/157 47.1 83/157 52.9 
 16 years 100/700  14.3 31/100 31.0 69/100 69.0 
 17 years 122/700  17.4 24/122 19.7 98/122 80.3 
 18 years 203/700  29.0 27/202 13.4 175/202 86.6 
 19 years 118/700 16.9 9/118 7.6 109/118 92.4 
 Ethnicity 
 
 
 
 
 
 0.42 
Ngäbe 607/665 91.3 133/606 21.9 473/606  78.1 
 Bugle 23/665 3.5 5/23 21.7 18/23 78.3 
 Mixed Latino/Ngäbe/Bugle 35/665 5.3 11/35 31.4 24/35 68.6 
 School grade 
 
 
 
 
 
 <0.01 
7-9th 168/698 24.1 70/167 41.9 97/167  58.1 
 10 119/698  17.0 34/119  28.6 85/119  71.4 
 11 162/698 23.2 26/162 16.0 136/162  84.0 
 12 249/698 35.7 35/249 14.1 214/249  85.9 
 Comarcal Region 
 
 
 
 
 
 <0.01 
Nidrini (previously Chiriquí) 335/700  47.9 80/335 23.9 255/335 76.1 
 Kädridri (previously Veraguas) 155/700  22.1 57/155 36.8 98/155 63.2 
 Ño Kribo (previously Bocas del Toro) 210/700  30.0 28/209 13.4 181/209 86.6 
 Access to cellular phone 
 
 
 
 
 
 0.70 
Personal cell phone 295/675  43.7 67/295 22.7 228/295 77.3 
 Shared cell phone 149/675  22.1 34/149 22.8 115/149  77.2 
 No access 231/675  34.2 59/230 25.7 171/230  74.4 
  
  
                                                     
1
 Denominators differ for each variable due to missing data 
2
 Difference between those who reported sexual activity and those who did not AC
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Table 2: Reported sexual behaviors among those who report history of sexual activity, by participant sex, Comarca Ngäbe-Bugle, 
Panama, 2018 
 
All participants
3
 
Sex   
 
 
Female  Male  p-value
4
 
 
n/N % n/N % n/N % 
 Reported age of sexual debut 
 
 
 
 
 
 0.58 
≤12 years 31/372 8.3 11/149 7.4 20/223  9.0 
 
13-16 years 248/372 
66.
7 104/149 
69.8 
144/223  
64.6 
 
17-19 years 93/372 
25.
0 34/149 
22.8 
59/223  
26.5 
 Reported age of partner at sexual debut 
 
 
 
 
 
 <0.01 
8-13 years 34/356 9.6 4/143 2.8 30/213  14.1 
 
14-19 years 283/356 
79.
5 109/143 
76.2 
174/213  
81.7 
 
20 years 39/356 
11.
0 30/143 
21.0 
9/213  
4.2 
 Reported total number of sex partners in lifetime 
 
 
 
 
 
 <0.01 
1 153/333 
46.
0 77/138 
55.8 
76/195  
39.0 
 
2 67/333 
20.
1 28/138 
20.3 
39/195  
20.0 
 
3 113/333 
33.
9 33/138 
23.9 
80/195  
41.0 
 Reported number of partners in past month 
 
 
 
 
 
 0.06 
0 218/488 
44.
7 90/211 
42.7 
128/277  
46.2 
 
1 191/488 
39.
1 95/211 
45.0 
96/277  
34.7 
 
2 52/488 
10.
7 16/211 
7.6 
36/277  
13.0 
 3  27/488 5.5 10/211 4.7 17/277  6.1 
 
                                                     
3
 Denominators differ for each variable due to missing data 
4
 Difference between male and female participants AC
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Reported same-sex sex partner 
 
 
 
 
 
 0.09 
No 359/395 
90.
9 152/162 
93.8 
207/233  
88.8 
 Yes 36/395 9.1 10/162 6.2 26/233  11.2 
Reported condom use at last sexual intercourse 
 
 
 
 
 
 <0.01 
No 247/312 
79.
2 101/133 
75.9 
146/179  
81.6 
 
During part of the time 48/312 
15.
4 18/133 
13.5 
30/179  
16.8 
 During the whole act 17/312 5.4 14/133 10.5 3/179  1.7 
 Has experienced forced sex
5
 
 
 
 
 
 
 <0.01 
Never 371/503 
73.
8 139/218 
63.8 
232/285  
81.4 
 
Yes, at least once 132/503  
26.
2 79/218 
36.2 
53/285  
18.6 
 Has been offered something in exchange for sex
6
 
 
 
 
 
 
 0.26 
No 429/509 
84.
3 180/219 
82.2 
249/290  
85.9 
 
Yes 80/509  
15.
7 39/219 
17.8 
41/290  
14.1 
  
  
                                                     
5
 Has been physically forced to engage in sex 
6
 Has been offered something (money, food, housing, a better grade) in exchange for sex. 
 AC
CE
PT
ED
28 
 
Table 3: Prevalence of sexually transmitted infections by sex, among sexually experienced 14-19-year-old school-going participants 
from the Comarca Ngäbe-Buglé, Panama, 2018 
  
 No reported sexual experience Reported sexual experience 
 Females Males Females Males p-Value7 
 n/N8 % 
(95%CI) 
n/N % 
(95%CI) 
n/N9  % 
(95%CI) 
n/N % 
(95%CI) 
 
Chlamydia trachomatis - - - - 39/224 17.4 
(13.0-23.0) 
31/291 10.7 
(7.6-14.8) 
0.03 
Neisseria gonorrhoeae - - - - 4/224 1.8 
(0.7-4.7) 
5/291 1.7 
(0.7-4.1) 
0.95 
Syphilis          
Treponemal seroreactivity10 0/83 0.0 0/89 0.0 8/228 3.5 
(1.8-6.9) 
22/287 7.7 
(5.1-11.4) 
0.05 
Active syphilis11 0/83 0.0 0/89 0.0 3/228 1.3 
(0.4-4.0) 
19/287 6.6 
(4.3-10.2) 
<0.0112 
Hepatitis B virus (HBV)          
HBsAg 0/82 0.0 0/90 0.0 3/233 1.3 
(0.4-3.9) 
4/293 1.4 
(0.5-3.6) 
0.93 
anti-HBc Ab 0/76 0.0 2/89 2.3 
(0.6-8.7) 
7/218 3.2 
(1.5-6.6) 
4/278 1.4 
(0.5-3.8) 
0.18 
HIV 0/83 0.0 0/90 0.0 1/228 0.4 
(0.0-3.1) 
3/287 1.0 
(0.3-3.2) 
0.44 
Herpes simplex virus type 2 
 (HSV-2) 
0/63 0.0 10/69 14.5 
(7.9-25.1) 
28/174 16.1 
(11.3-22.4) 
35/217 16.1 
(11.8-21.7) 
0.99 
Vaginal flora in all girls – Nugent’s 
score 
         
Normal (Score 0-3) 40/61 65.6 
(52.6-76.6) 
- - 84/182 46.2 
(39.0-53.5) 
- - - 
Intermediate (Score 4-6) 9/61 14.8 
(7.8-26.3) 
- - 20/182  11.0 
(7.2-16.5) 
- - - 
BV (Score 7-10) 12/61 19.7 
(11.4-31.8) 
- - 78/182 42.9 
(35.8-50.2) 
- - - 
                                                     
7
 2 was used to evaluate differences between in prevalence between male and female participants 
8
 Differences in the total number of tests taken due to lack of quality sample in some instances 
9
 Differences in the total number of tests taken due to lack of quality sample in some instances 
10
 Positive syphilis rapid test 
11
 Treponemal antibody confirmed active syphilis cases with VDRL 
12
 Kruskal-Wallis Test for trend statistically significant at p<0.05 are presented in bold AC
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High-risk HPV in all girls          
Genotype 16 0/0 0.0 - - 0/0 0.0 - - - 
Genotype 18 0/0 0.0 - - 0/0 0.0   - 
Other HR genotypes13 6/57 10.5 
(4.7-21.8) 
- - 63/190 33.2 
(26.8-40.2) 
- - - 
 
  
                                                     
13
 Other high-risk types include: 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 AC
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Supplementary Table 1: Questions on sexual activity to indicate ´reported sexual activity´ 
 
 
 
 
 
 
 
 
 
 
 
 
Reported sexual activity 
Question Possible answers, reported sex activity in bold 
Have you ever engaged in sex? No, never/Yes  
Have you ever had vaginal sex? No, never/Yes 
Have you ever had oral sex? No, never/Yes 
Have you ever had anal sex? No, never/Yes 
Who have you had sex with? I’ve never had sex, boy/boys/man/men, a 
girl/girls/woman/women, an animal, I don’t 
want to answer 
Sexual network questions (in the last three 
romantic relationships, did you have sex with 
this person?) 
No and it will never happen, No but in the 
future we will, yes once, yes more than once, I 
don’t want to answer 
How many sex partners have you had ever? 0, 1, 2, 3, 4 or more 
Sometime, when you didn’t want to, did 
someone force you to have sex with them? 
No, never, yes once, yes more than once 
Do you use a condom when you have sex? I’ve never had sex, No but I’ve only had sex 
once, yes but I’ve only had sex once, during 
part of the act, I always use a condom, I never 
use a condom 
Reported STI symptoms Have you ever had any of the following 
symptoms in your intimate parts: 
None of the below, discharge from vagina, 
discharge from penis, an ulcer on genitals or 
anus, swollen groin lymph nodes 
Reported STI diagnosis Has a doctor at a health center ever told you 
have any of the following problems: 
None of the below, discharge from vagina, 
discharge from penis, gonorrhea or chlamydia, 
syphilis, hepatitis B, genital herpes, HIV, I 
don’t remember what they told me but they 
said I had an infection from having sex 
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Supplementary Figure 1: Prevalence of infections, among adolescents who have engaged in sex, by 
age, Comarca Ngäbe-Buglé, Panamá, 2018 
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Supplementary Table 2: Risk factors of genital Chlamydia trachomatis (CT) infection 
among male and female sexually-experienced participants Comarca Ngäbe-Bugle, Panama, 
2018 
 
 Yes p-value OR (95%CI) p-value AOR (95%CI) p-value 
 n/N (%)          
Participant sex  0.03 1.77 (1.06-2.94) 0.03 2.02 (1.20-3.41) <0.01 
Female 39/224 (17.4)          
Male 31/291 (10.7)          
Age  0.37 1.23 (1.00-1.51) 0.05 1.30 (1.05-1.60) 0.02 
14-15 years 6/71 (8.5)          
16 years  7/65 (10.8)          
17 years 13/98 (13.3)          
18 years 24/173 (13.9)          
19 years 20/108 (18.5)      3.0 (1.12-8.07)   
Comarcal Region  0.43 1.20 (0.91-1.59) 0.19 1.21 (0.91-1.60) 0.2 
Nidrini (Chiriquí) 29/248 (11.7)          
Kädridri (Veraguas) 13/93 (14.0)          
Ño Kribo (Bocas del Toro) 28/174 (16.1)          
Forced sex14  0.47         
No 46/355 (13.0)          
Yes 20/129 (15.5)  0.72 (0.24-2.11) 0.55     
Transactional sex15   0.86         
No 55/410 (13.4)          
Yes 10/79 (12.7)      
       
Number of partners in 
lifetime 
 0.24 
1.20 (0.85-1.69) 0.31     
1 17/152 (11.2)          
2 13/66 (19.7)          
3 or more 17/112 (15.2)          
Same-sex sex partner  0.54 1.06 (0.78-1.44) 0.71     
No 52/350 (14.9)          
Yes 4/36 (11.1)          
 
AOR= adjusted odds ratio; CI = confidence interval; OR = odds ratio 
 
 
 
  
                                                     
1
Has been physically forced to engage in sex 
2
Has been offered something (money, food, housing, a better grade) in exchange for sex. 
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Supplementary Table 3: Risk factors of active syphilis among male and female sexually-
experienced participants Comarca Ngäbe-Bugle, Panama, 2018 
 
 
 
 Yes p-value OR (95%CI) p-value AOR (95%CI) p-value 
 n/N (%)      
Sex of participant  <0.01 5.16 (1.50-17.76) 0.01 4.51 (1.17-17.40) 0.02 
Female 3/235 (1.3)      
Male 19/299 (6.4)      
Age  0.18 1.49 (102-2.21) 0.040 1.08 (0.74-1.58) 0.14 
14-15 years 1/85 (1.2)  1.00    
16 years  1/69 (1.5)  1.22 (0.07-20.14)    
17 years 5/97 (5.2)  4.62 (0.52-40.86)    
18 years 7/175 (4.0)  3.20 (0.38-27.23)    
19 years 8/108 (7.4)  6.35 (0.77-52.60)    
Comarcal Region   1.13 (0.60-2.13) 0.7   
Nidrini (Chiriquí) 9/255 (3.5) 0.54 1.00    
Kädridri (Veraguas) 6/98 (6.1)  1.71 (0.47-6.21)    
Ño Kribo (Bocas del Toro) 7/181 (3.9)  1.20 (0.36-4.08)    
Forced sex16  0.08 2.14 (0.88-5.24) 0.09 2.43 (0.89-6.62) 0.08 
No 12/365 (3.3)      
Yes 9/131 (6.9)      
Transactional sex17   0.02 2.83 (1.09-7.29) 0.03 2.49 (0.82-7.57) 0.11 
No 14/427 (3.3)      
Yes 7/79 (8.9)      
Number of partners in lifetime  0.84 1.03 (0.56-1.95) 0.89   
1 5/149 (3.4)  1.00    
2 4/66 (6.1)  1.86 (0.48-7.16)    
3 or more 4/113 (3.5)  1.06 (0.28-4.03)    
Same-sex sex partner  0.05 3.68 (1.06-12.81) 0.04 1.97 (0.53-7.32) 0.32 
No 14/349 (4.0)      
Yes 4/36 (11.1)      
 
AOR= adjusted odds ratio; CI = confidence interval; OR = odds ratio 
  
                                                     
16
 Has been physically forced to engage in sex 
17
 Has been offered something (money, food, housing, a better grade) in exchange for sex. 
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Supplementary Table 4: Risk factors of herpes simplex virus type-2 (HSV-2) infection among 
male and female sexually-experienced participants Comarca Ngäbe-Bugle, Panama, 2018  
 
 
 
 Yes p-value OR (95%CI) p-value AOR (95%CI) p-value 
 n/N (%)        
Participant sex  0.99 1.43 (0.81-2.50)  0.22  1.32 (0.75-2.33)   0.34 
Female 28/174 (16.1)          
Male 35/217 (16.1)          
Age  0.97 1.05 (0.86-1.23)  0.62 0.97 (0.78-1.21)   0.82 
14-15 years 13/70 (18.6)          
16 years  11/56 (19.6)          
17 years 13/81 (16.1)          
18 years 22/123 (17.9)          
19 years 14/76 (18.4)          
Comarcal Region  <0.01 2.12 (1.53-2.95) <0.01 2.10 (1.50-2.96) <0.01 
Nidrini (Chiriquí) 27/247 (10.9)      1.0    
Kädridri (Veraguas) 10/59 (17.0)      1.71 (0.73-3.98)   
Ño Kribo (Bocas del Toro) 36/100 (36.0)      4.50 (2.38-8.52)   
Forced sex18  0.19 0.56 (0.27-1.14)   0.11  0.84 (0.39-1.80) 0.65 
No 52/281 (18.5)         
Yes 12/95 (12.6)          
Transactional sex19   0.81 1.07 (0.50-2.27)  0.87    
No 57/328 (17.4)          
Yes 11/59 (18.6)      
Number of partners in 
lifetime 
 0.61 
1.17 (0.78-1.76)  0.44      
1 15/113 (13.3)          
2 7/47 (15.9)          
3 or more 16/87 (18.4)          
Same-sex sex partner  0.39 2.14 (0.75-6.13) 0.16  2.41 (0.80-7.23)  0.12 
No 41/259 (15.8)          
Yes 6/27 (22.2)          
 
AOR= adjusted odds ratio; CI = confidence interval; OR = odds ratio 
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Supplementary Table 5: Risk factors of bacterial vaginosis (BV) among all female participants 
Comarca Ngäbe-Bugle, Panama, 2018  
 
 Yes p-value OR (95%CI) p-value AOR (95%CI) p-value 
 n/N (%)      
Age   0.15 1.15 (0.94-1.40) 0.16 1.07 (0.87-1.31) 0.52 
14-15 years 20/59 (33.9)  1.00    
16 years  12/42 (28.6)  0.68 (0.27-1.69)    
17 years 14/44 (31.8)  0.81 (0.34-1.93)    
18 years 32/64 (50.0)  1.93 (0.90-4.13)    
19 years 12/34 (35.3)  1.11 (0.45-2.77)    
Ever had sex  <0.01 3.01 (1.48-6.11) 0.002 2.86 (1.39-5.91) <0.01 
No 12/61 (19.7)      
Yes 78/182 (42.9)      
Comarcal Region  0.06 1.39 (0.97-1.99) 0.07 1.36 (0.99-1.90) 0.02 
Nidrini (Chiriquí) 30/95 (31.6)  1.00  1.00  
Kädridri (Veraguas) 22/68 (32.4)  1.02 (0.49-2.14)  1.06 (0.52-2.17)  
Ño Kribo (Bocas del Toro) 38/80 (47.5)  1.94 (0.99-3.81)  2.01 (1.06-3.86)  
Forced sex20  0.47 0.90 (0.47-1.70) 0.74   
No 46/355 (13.0)      
Yes 20/129 (15.5)      
Transactional sex21   0.96 1.06 (0.49-2.29) 0.88   
No 73/193 (37.8)      
Yes 13/34 (38.2)      
Number of partners in 
lifetime 
 0.03 1.81 (1.14-2.89) 0.01 1.86 (1.10-3.14) 0.02 
1 23/64 (35.9)  1.00  1.00  
2 11/26 (42.3)  1.31 (0.51-3.34)  1.13 (0.40-3.18)  
3 or more 18/27 (67.7)  3.58 (1.38-9.30)  3.81 (1.29-11.26)  
Same-sex sex partner  0.05 5.89 (1.04-33.39) 0.07 4.68 (0.87-25.11) 0.07 
No 53/121 (43.8)      
Yes 7/9 (77.8)      
 
AOR= adjusted odds ratio; CI = confidence interval; OR = odds ratio 
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Supplementary Table 6: Risk factors of high-risk human papilloma virus (HPV) infection 
among all female participants of the Comarca Ngäbe-Bugle, Panama, 2018  
 
 
 Yes p-value OR (95%CI) p-value AOR (95%CI) p-value 
 n/N (%)           
Age   0.59          
14-15 years   
 
1.14 (0.93-1.39) 0.20 1.05 (0.86-1.29)  0.63 
16 years  13/60 (21.7)           
17 years 11/42 (26.2)           
18 years 12/43 (27.9)           
19 years 23/66 (34.9)           
Ever had sex 10/36 (27.8) <0.01  4.22 (1.71-10.35) <0.01 4.05 (1.62-10.09) <0.01 
No   
 
        
Yes 6/57 (10.5)           
Comarcal Region 63/190 (33.2) 0.55          
Nidrini (Chiriquí)   
 
1.20 (0.86-1.66) 0.28     
Kädridri (Veraguas) 24/97 (24.7)           
Ño Kribo (Bocas del Toro) 19/69 (27.5)           
Forced sex22 4/9 (44.4)  0.35 0.64 (0.34-1.18) 0.42   
No            
Yes 41/92 (44.6)           
Transactional sex23  5/15 (33.3) 0.42          
No 3/12 (25.0)   1.30 (0.69-2.46) 0.42     
Yes            
Number of partners in 
lifetime 8/24 (33.3)  0.96 1.01 (0.64-1.58) 0.97     
1   
 
        
2 28/68 (41.2)           
3 or more 10/26 (38.5)           
Same-sex sex partner  0.74 1.26 (0.32-4.91) 0.74     
No 2/9 (22.2) 
 
        
Yes 49/126 (38.9)           
 
AOR= adjusted odds ratio; CI = confidence interval; OR = odds ratio 
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